MassRobotics has opened applications for the sixth cohort of its Healthcare Robotics Startup Catalyst Program, bringing Intel (NASDAQ: INTC) onto the steering committee to support startups developing robotics and automation technologies for healthcare and life sciences.
The four-month, non-equity program will run from February through June 2027. Applications opened October 15 and close December 31, 2026. The initiative connects early- and growth-stage companies with engineering specialists, industry mentors and clinicians to help advance technical validation, clinical readiness and commercialization.
Intel joins founding partners Festo, Mitsubishi Electric US and Novanta (NASDAQ: NOVT). Its Health and Life Sciences team will contribute expertise in edge artificial intelligence (AI) and on-device computing, particularly for surgical robotics, procedure-enabling systems and operating room automation.
The addition reflects the growing importance of computing architectures that can process data close to where it is generated. In healthcare robotics, local processing can support applications that require timely analysis of sensor inputs and consistent system responses.
Edge AI and Motion Control in Healthcare Robotics
Healthcare robotics combines several electronics and engineering disciplines, including embedded computing, sensors, precision motion control, machine vision and software. These technologies enable robots to perform tasks ranging from laboratory automation and diagnostic workflows to surgical assistance and hospital logistics.
Edge AI allows computing systems to run AI workloads locally on a device or nearby computing platform rather than relying entirely on remote cloud infrastructure. For medical and surgical robotics, this approach can help reduce dependence on network connectivity and support low-latency processing. Actual performance depends on the system architecture, workload and implementation.
Intel’s participation will focus on technical mentorship related to edge AI and on-device computing. The program also draws on Festo’s automation expertise, Mitsubishi Electric US’s industrial and motion-control capabilities, and Novanta’s experience in precision technologies. Mentors from yaxxoo and practicing clinicians will contribute to the program.
The combination of computing, motion and sensing expertise is relevant to robotics developers working to translate prototypes into systems that can operate within clinical environments. Such systems must address technical integration alongside practical requirements, including clinical workflows, cybersecurity and regulatory planning.
Startups Receive Technical and Clinical Mentorship
The Catalyst Program is designed to help participating companies establish practical development milestones. These can include proof-of-concept builds, pilot planning, systems integration and preparation for regulatory requirements.
Participants receive tailored mentorship, biweekly working sessions and access to a Medical Advisory Board. Workshops will address topics such as clinical workflow, cybersecurity, software bills of materials (SBOMs), regulatory strategy and pilot design.
Eligible companies can be based anywhere in the world and may range from Seed-stage startups to businesses at Series C. Focus areas include laboratory and pharmaceutical automation, diagnostics and imaging, rehabilitation devices, surgical and interventional robotics, hospital logistics, precision motion, sensing and medical-device cybersecurity.
MassRobotics will assess applicants based on technical maturity, clinical relevance, near-term feasibility, program fit and alignment with available mentors. Teams able to pursue a proof of concept during the program are particularly encouraged to apply.
The cohort will conclude with company showcases at the Robotics Summit and Expo in Boston in June 2027. The program is intended to help startups refine their technologies and prepare for commercial adoption, although participation does not guarantee pilot deployments or commercial contracts.
Program Builds on Earlier Startup Cohorts
Since 2021, the program has mentored 35 startups, with participating companies based in locations including Boston, Toronto, Paris, Barcelona and Sydney. According to MassRobotics, alumni have collectively disclosed more than $180 million in funding raised and advanced multiple proof-of-concept deployments. The organization also reported that one alumnus completed a public listing.
For electronics and automation suppliers, the program offers a way to engage with emerging applications for computing, sensors, motion systems and industrial automation in healthcare. For startups, access to technical specialists and clinical perspectives can help identify integration challenges earlier in product development.
Applications will be evaluated between January 1 and January 20, 2027, with the new cohort scheduled to be announced on January 29. The program will run from February through June.
